EMBT

EMBER THERAPEUTICS INC by Ember Therapeutics, Inc. (EMBT)

About EMBER THERAPEUTICS INC by Ember Therapeutics, Inc. (EMBT)

Ember Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the provision of treatment for metabolic disorders and obesity diseases. Its focuses on utilizing Bone Morphogenetic Protein-7 and related family of Bone Morphogenetic Proteins, mutants, variants, novel formulations, and delivery technologies to develop regenerative medicines for disease modification of osteoarthritis. The company was founded on January 20, 1987 and is headquartered in New York, NY.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
0
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--

EMBER THERAPEUTICS INC by Ember Therapeutics, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
0
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--